Delivery Order SPE2DE24DA017-SPE2D625F2KGZ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology leader, was awarded a $19.8K delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 8, 2025, and represents the final delivery location as Naples, FL. The award carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc. was awarded a $4,950 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the Arthrex ACP Double Syringe System, with an ultimate completion date of July 24, 2025. The award represents a non-set-aside contract and is being performed at Arthrex's Naples, Florida location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- Arthrex Inc. has been awarded a delivery order valued at $16,500 for the Arthrex ACP Double Syringe System under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, with an ultimate completion date of August 6, 2025, was made by the Defense Logistics Agency's Medical Supply Chain to support federal healthcare requirements. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters. This delivery order was not set...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $3,300 on September 9, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment features an ultimate completion date of September 12, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Medical Supply Chain. The contract is not set aside for any...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F2KGZDelivery Order
Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $9,900 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on September 3, 2025, with an ultimate completion date of September 17, 2025. The award represents a non-set-aside competitive procurement and will be performed at Arthrex's facility in Naples, Florida. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (IDC) SPE2DE24D0020 with the Defense Logistics Agency, valued at approximately $471 million and spanning from June 2024 through September 2029. This comprehensive IDC enables Veterans Affairs medical centers nationwide to acquire Arthrex's orthopedic surgical technologies, including implants, arthroscopic instruments, and specialized surgical systems. The ACP Double Syringe System represents a specific orthopedic product delivery within this framework, supporting the company's continued provision of advanced medical devices to government healthcare systems serving veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/3/25 |